share_log

BRIEF-Halozyme Therapeutics Inc - 2021 Revenue Guidance Range of $375 Mln To $395 Mln

路透社 ·  Jan 11, 2021 21:49
Jan 11 (Reuters) - Halozyme Therapeutics Inc :
   * 2021 REVENUE GUIDANCE OF $375 TO $395 MILLION
   * 2021 EPS GUIDANCE OF $1.40 TO $1.55
   * FY2021 EARNINGS PER SHARE VIEW $1.79, REVENUE VIEW $403.7 MILLION -- REFINITIV IBES DATA

Source text for Eikon:  Further company coverage:

((Reuters.Briefs@thomsonreuters.com;)
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment